Medtronic plc.

Open: 82.79 Close: 81.39 Change: -1.4

The top 9 things about Medtronic plc. Company Inc Stock found by an AI.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, company, revenue, raise, fiscal, report, PLC, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC stock outperforms competitors despite losses on the day. Shares closed $11.00 below its 52-week high ($92.39) Medtronics stock outperform competitors despite losing on the the day.

Today's News

Medtronic PLC stock outperforms competitors despite losses on the day - marketwatch.com. Medtronics stock outperform competitors despite losing on the the day. Shares closed $11.00 below its 52-week high ($92.39) Medtronic raises profit forecast as surgeries return to pre-pandemic levels. The return of non-urgent surgery volumes boosted demand for its medical devices, sending its shares up 3%. The beta is 0.72, so Medtronics price volatility has been lower than the market average. Medtronic ( NYSE:MDT – Get Free Report ) last posted its earnings results on Tuesday, August 22nd. The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Medtronic has raised its projected organic revenue growth for FY24 to 4.5%. The company recorded revenues of $7.7bn in the first quarter of fiscal year 2024 (FY24), a decrease of 15%. Medtronic PLC shares MDT, -0.05% were down 1.3% premarket on Thursday after advisors to the U.S. voted against use of hypertension treatment device. The company reported Q1 worldwide revenue of $7.702 billion. Medtronic reports first quarter fiscal 2024 financial results. Q1 worldwide revenue of $7.702 billion increased 4.5% as reported and 6.0% on an organic basis. Medtronic reported adjusted earnings per share (EPS) of $1.20 for first-quarter fiscal 2024 compared with the year-ago quarters EPS of $ 1.13. The company raised fiscal 2024 guidance. Medtronic released its quarterly earnings data on August 22nd, generating significant attention from analysts and investors alike. The company recorded revenue amounting to $7.70 billion for the quarter—a slight increase compared to the consensus estimate of $7.57 billion. Analysts are optimistic about Medtronics future projections and expect it to continue delivering impressive results throughout the current year. Medtronic to participate in upcoming investor conferences. Company raised full year organic revenue growth and EPS guidance. Medtronic recently partnered with Allurion on June 6, 2023. The partnership will help accelerate adoption of our Iris AI Platform. Medtronic to participate in upcoming investor conferences. WFC : 41.88 (+1.58%) MS : 84.38 (-1.38%) BAC : 28.76 (+0.91%) MDT : 81.39 (-0.97%) The intrinsic value of one MDT stock under the Base Case scenario is 93.81 USD. Compared to the current market price of 81.39 USD , Medtronic PLC is Undervalued by 13%. Medtronic is in the Health Care sector and Health Care Equipment & Supplies industry. The company is in a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, company, revenue, raise, fiscal, report, PLC, and the most common words in the summary are: medtronic, stock, market, mdt, plc, news, best, . One of the sentences in the summary was: Medtronic PLC stock outperforms competitors despite losses on the day. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #market #mdt #plc #news #best.